307 results - The Consciousness Library

Psilocybin After Trauma Surgery for Pain (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1 70 participants Trent Emerick

Pain Management, Postoperative Pain

MLS101 Study in PMDD (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1 32 participants MycoMedica Life Sciences PBC

Premenstrual Dysphoric Disorder ( PMDD), PMDD

Psilocybin Effects on Healthy Aging Biomarkers and Purpose in Life (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1 50 participants Charles Raison

Aging, Longevity, Biomarkers of Aging

Pilot Study on the Effects of Psilocybin on Belief Updating and Insight Formation (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1 24 participants Brown University

Phase I

Oral and Sublingual Ketamine (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1 10 participants Western University, Canada

Major Depression Severe

Psilocybin for Chronic Pelvic Pain (CPP) in Women: A Pilot Feasibility Study (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1 15 participants Oregon Health and Science University

Chronic Pelvic Pain

Psilocybin Efficacy With or Without Pimavanserin Pretreatment (opens ClinicalTrials.gov in a new tab)

Recruiting Phase 1/2 20 participants Johns Hopkins University

Mood (Psychological Function), Well Being, Mood, Healthy

Psilocybin for Treatment of OCD-2 (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1/2 20 participants Francisco A Moreno

Obsessive - Compulsive Disorder

The Acute Effects of Psilocybin on Cognition, Memory, and Brain Function (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1/2 48 participants Manoj Doss

Healthy

Wayne State Warriors Marijuana Clinical Research Program: Cannabinoid Adjunct to Prolonged Exposure & Recovery (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1/2 280 participants Leslie Lundahl

PTSD, Post Traumatic Stress Disorder, Suicide, Cannabis Use

Neural Effects of Intravenous N,N-dimethyltryptamine (DMT) (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1 20 participants Jon Dean

Healthy Participants Study

Pregnenolone for Cannabis Use Disorder and Depression (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1/2 20 participants University of Texas Southwestern Medical Center

Cannabis Use Disorder, Major Depressive Disorder (MDD)

Psilocybin as a Novel Therapy for Residual Anhedonia (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1 90 participants NYU Langone Health

Anhedonia, Emotional Blunting

The Effects of Psilocybin in Healthy Volunteers: Psychological, Biochemical and Electrophysiological Biomarkers. (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1 50 participants Gabriella Gobbi

Healthy Participants, Placebo - Control, Psilocybin

Consciousness and Psilocybin Effects on Well-Being: The CoPEWell Study (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1 120 participants University of Wisconsin, Madison

Well-Being, Psychological, Psychedelic Experiences

Shortened LSD Intervention for Major Depressive Disorder (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1 10 participants Johns Hopkins University

Major Depression Moderate, Major Depression Severe, Major Depression

The Effects of Psilocybin on Social Connectedness (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1 51 participants Yale University

Loneliness, Grief

Psilocybin to Treat Depression in Spinal Cord Injury (opens ClinicalTrials.gov in a new tab)

Recruiting Phase 1/2 30 participants James J. Peters Veterans Affairs Medical Center

Spinal Cord Injury, Depression - Major Depressive Disorder, Veteran

Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1/2 50 participants Indiana University

Treatment Resistant Depression, Substance Use Disorders

Effects of a Sigle Dose of Ayahuasca in Patients With Psychogenic Non-epileptic Seizures: an Open Label Clinical Trial (opens ClinicalTrials.gov in a new tab)

Recruiting Phase 1/2 15 participants University of Sao Paulo

Non Epileptic Seizures

Cannabidiol Oil for Treatment-Resistant Major Depression (opens ClinicalTrials.gov in a new tab)

Recruiting Phase 1/2 120 participants Universidade do Sul de Santa Catarina

Major Depressive Disorder (MDD), Treatment-resistant Depression (TRD)

A Study of Psychedelics in Healthy Older Adults With Low Well-being (opens ClinicalTrials.gov in a new tab)

Recruiting Phase 1 80 participants Jennifer Mitchell

Anhedonia in Healthy Volunteers, Older Adults (50-90 Years)

MDMA Assisted Therapy for BN (opens ClinicalTrials.gov in a new tab)

Recruiting Phase 1 40 participants Icahn School of Medicine at Mount Sinai

Bulimia Nervosa

Psilocybin Whole Mushroom for the Treatment of Obsessive-compulsive Disorder. (opens ClinicalTrials.gov in a new tab)

Recruiting Phase 1 30 participants Francisco A Moreno

Obsessive-Compulsive Disorder

Group Psilocybin-Assisted Therapy for Post-Traumatic Stress Disorder (opens ClinicalTrials.gov in a new tab)

Recruiting Phase 1 36 participants University of New Mexico

PTSD